$IDRA News Bears chip away at the SP 1,775 support 11:01

New Post Public Reply Private Reply Replies (0) Message Board

Feb 20, 2014 at 12:56 PM

$IDRA News

Bears chip away at the S&P 1,775 support 11:01 a.m. Feb. 3, 2014 - Michael Ashbaugh
Charting a bullish early-2014 outlook 12:05 p.m. Dec. 31, 2013 - Michael Ashbaugh
Charting a bullish early-2014 outlook 11:39 a.m. Dec. 31, 2013 - Michael Ashbaugh
S&P, Nasdaq rally from major support 11:09 a.m. Dec. 16, 2013 - Michael Ashbaugh
Pfizer, Affymetrix weigh on drug stocks 2:04 p.m. July 7, 2011 - Val Brickates Kennedy
Idera tumbles 14% on drug setback 1:52 p.m. July 7, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:37 p.m. Jan. 19, 2010 - MarketWatch
Incyte, Idera move on Novartis deals 2:02 p.m. Nov. 25, 2009 - Val Brickates Kennedy
Novartis terminates pact with Idera 8:28 a.m. Nov. 25, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:29 p.m. Dec. 26, 2007 - MarketWatch
Idera Pharmaceuticals' president, Karr, resigns 9:08 a.m. Dec. 26, 2007 - Robert Daniel
Idera Pharma President Karr resigns, stays on board 9:03 a.m. Dec. 26, 2007 - Robert Daniel
Idera signs agonist licensing, collaboration with Merck KGaA 7:10 a.m. Dec. 19, 2007 - Sarah Turner
Idera to get up to $381 mln in milestones 7:03 a.m. Dec. 19, 2007 - Steve Goldstein
Idera, Merck KGaA agree collaboration deal 7:02 a.m. Dec. 19, 2007 - Steve Goldstein
Wednesday's biggest stock gainers and decliners 6:03 p.m. Feb. 28, 2007 - Michael Baron
Idera Pharma started at buy at Merriman Curhan Ford 8:54 a.m. Feb. 7, 2007 - Tomi Kilgore
Drug stocks slip; Nuvelo, Neopharm shares plunge on trial results 4:37 p.m. Dec. 11, 2006 - Carolyn Pritchard

Idera Pharmaceuticals: Set To Ride A 200% Gain In 2014 9:38 a.m. Jan. 31, 2014 - Seeking Alpha
First Week Of IDRA March 22nd Options Trading 10:54 a.m. Jan. 23, 2014 - TheStreet.com
Perilous Reversal Watch: Idera Pharmaceuticals (IDRA) 9:47 a.m. Jan. 23, 2014 - TheStreet.com
Good Action Under the Surface 4:45 p.m. Jan. 22, 2014 - RealMoney.com
Price Action Tells the Story 2:05 p.m. Jan. 22, 2014 - RealMoney.com
Tricky and Misleading Action 10:45 a.m. Jan. 22, 2014 - RealMoney.com
Idera Pharmaceuticals Presents a Promising Opportunity 2:23 p.m. Dec. 26, 2013 - Wall St. Cheat Sheet
Friday’s Biggest Stock Losers: INSY OPK, and More 7:52 a.m. Dec. 13, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Dec. 11, 2013 - InvestorPlace.com
10-Q: IDERA PHARMACEUTICALS, INC. 7:02 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech-Focused Baker Bros. Accumulates These 3 Stocks 8:55 a.m. Oct. 1, 2013 - Seeking Alpha
Idera Phase 2 Data Provides For Exciting Q4 2013 And Q1 2014 8:02 a.m. Sept. 25, 2013 - Seeking Alpha
Analysts: Blackstone Mortgage Gaining Traction and 3 Other Research Notes to Browse 1:37 p.m. Aug. 29, 2013 - Wall St. Cheat Sheet
Idera Enters Agreement with NCI to Evaluate Use of TLR Antagonists for Treatment of Genetically Defined Lymphomas 6:39 a.m. Aug. 29, 2013 - benzinga.com
Idera Announces Issuance of US Patent Covering IMO-8400, Lead Candidate in Phase 2 Trial 6:05 a.m. July 18, 2013 - benzinga.com
Idera Pharma to Issue Positive Phase I Trial Results on TLR Antagonist IMO-8400 5:31 a.m. June 21, 2013 - benzinga.com
Idera Pharmaceuticals Announces Initiation of a Phase 2 Trial of IMO-8400 in Patients with Moderate to Severe Plaque Psoriasis 6:07 a.m. June 5, 2013 - benzinga.com
10-Q: IDERA PHARMACEUTICALS, INC. 6:49 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Idera Pharmaceuticals Announces Closing of Common Share Offering 2:19 p.m. May 7, 2013 - benzinga.com
Idera Pharmaceuticals Prices 17.5M Share Offering at $0.50/Share 3:59 a.m. May 2, 2013 - benzinga.com

Idera to Present at the 2014 RBC Capital Markets’ Global Healthcare Conference 4:02 p.m. Feb. 18, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 4:15 p.m. Feb. 10, 2014 - BusinessWire - BZX
Idera to Present at 16th Annual BIO CEO & Investor Conference 8:30 a.m. Feb. 6, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stockand Pre-Funded Warrants 9:10 a.m. Feb. 5, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Public Offering of Common Stock and Pre-Funded Warrants 4:01 p.m. Feb. 4, 2014 - BusinessWire - BZX
Idera Announces Publication of New Data Demonstrating Impact of Inhibiting TLRs 7, 8, and 9 in a Preclinical Model of Autoimmune Disease 8:01 a.m. Jan. 22, 2014 - BusinessWire - BZX
Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine 8:00 a.m. Jan. 9, 2014 - PR Newswire
Idera Expands Leadership Team and Strengthens Clinical Development Expertise in Oncology and Orphan Diseases 8:00 a.m. Jan. 9, 2014 - BusinessWire
Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera 8:00 a.m. Dec. 31, 2013 - PR Newswire
Senior Appointments, Stock Splits, New Guidelines, Positive Results, and Clinical Trial Updates - Research Report on Receptos, MEDNAX, CombiMatrix, Anacor, and Idera 8:00 a.m. Dec. 10, 2013 - PR Newswire
Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenstrom's Macroglobulinemia 7:30 a.m. Dec. 4, 2013 - BusinessWire
Idera Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 4:02 p.m. Nov. 25, 2013 - BusinessWire
Idera Pharmaceuticals Reports Third Quarter 2013 Financial Results and Provides Corporate Update 7:45 a.m. Nov. 14, 2013 - BusinessWire
Idera Pharmaceuticals to Host Conference Call to Report Third Quarter 2013 Financial Results on Thursday, November 14, 2013 4:10 p.m. Nov. 7, 2013 - BusinessWire
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 3:14 p.m. Sept. 30, 2013 - BusinessWire
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants 8:09 a.m. Sept. 25, 2013 - BusinessWire
Idera Pharmaceuticals Announces Public Offering of Common Stock and Pre-Funded Warrants 3:01 p.m. Sept. 24, 2013 - BusinessWire
Five Star Equities Issues New Research Reports on EZCH, IDRA, PSTI and UNFI 8:01 a.m. Sept. 13, 2013 - ACCESSWIRE
Idera to Provide Update on Programs at Stifel Nicolaus Healthcare Conference 11:00 a.m. Sept. 12, 2013 - BusinessWire
Idera to Present at the Stifel Nicolaus 2013 Healthcare Conference 8:25 a.m. Sept. 10, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...